CVS Health Corporation (CVS)
NYSE
94.11
+1.09 (+1.17%)
Closed
Aug 24, 2026
Day's Range
92.5494.18
52 wk Range
69.51110.68
Financial Statements - CVS - CVS Health Corporation
Revenue
402.06B▲ 7.8%
Net Income
1.72B▼ 62.3%Net Margin 0.4%
EBITDA
15.10B▲ 4.2%
Free Cash Flow
7.80B▲ 23.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 402.06B | 372.80B | 357.77B | 322.46B | 292.11B | 268.70B |
| Cost of Goods | 346.70B | 321.40B | 303.34B | 267.96B | 239.99B | 219.66B |
| Gross Profit | 55.36B | 51.40B | 54.43B | 54.50B | 52.12B | 49.04B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 10.38B | 9.79B | 14.59B | 16.29B | 15.09B | 13.91B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -5.13B | -689M | -768M | -8.16B | -2.05B | -1.23B |
| Pre Tax Income | 2.13B | 6.14B | 11.17B | 5.83B | 10.53B | 9.77B |
| Income Tax | 408M | 1.56B | 2.80B | 1.50B | 2.54B | 2.56B |
| Net Income | 1.72B | 4.58B | 8.36B | 4.32B | 7.98B | 7.19B |
| EPS Basic | 1.4 | 3.67 | 6.49 | 3.29 | 6 | 5.48 |
| EPS Diluted | 1.39 | 3.66 | 6.47 | 3.26 | 5.95 | 5.46 |
| Basic Shares Outstanding | 1.26B | 1.25B | 1.28B | 1.31B | 1.31B | 1.30B |
| Diluted Shares Outstanding | 1.26B | 1.25B | 1.28B | 1.31B | 1.31B | 1.30B |
| Ebit | 5.25B | 9.10B | 13.83B | 8.12B | 13.04B | 12.67B |
| Ebitda | 15.10B | 14.49B | 19.05B | 20.68B | 19.76B | 18.55B |
| Net Income Continuous Operations | 1.72B | 4.58B | 8.36B | 4.32B | 7.98B | 7.19B |
| Minority Interests | 40M | 28M | -24M | -16M | 12M | -13M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
